Results 61 to 70 of about 44,369 (290)
Mechanisms of termination and prevention of atrial fibrillation by drug therapy [PDF]
, 2011 Atrial fibrillation (AF) is a disorder of the rhythm of electrical activation of the cardiac atria. It is the most common cardiac arrhythmia, has multiple aetiologies, and increases the risk of death from stroke.
Smith, G.L. +5 more
core +1 more source
Hydroxamic Acids as HDAC Inhibitor Drug Leads for Malaria
Medicinal Research Reviews, EarlyView.ABSTRACT Malaria is a global health threat, with an estimated 282 million cases and 610,000 malaria‐associated deaths reported in 2024. Most mortality is due to infection by Plasmodium falciparum parasites, with the highest burden occurring in Sub‐Saharan Africa.
Wisam A. Dawood +7 more
wiley +1 more source
antiarrhythmic pharmacotherapy during SARS-COV-2 pandemic
, 2021 This thesis offers a review of antiarrhythmic drugs with an emphasis on antiarrhythmic therapy during SARS-CoV-2 pandemic. Includes the general mechanisms causing arrhythmias with and without SARS-CoV-2 infection.
Meltzer, Maya Di
core
Acta Ophthalmologica, EarlyView.Abstract Purpose To identify associations between systemic drugs and cataract surgery in Finland. Methods A historic cohort study based on administrative data. Endpoint event was cataract surgery. Use of drugs in question was based on redeemed prescriptions and consisted of 156 drugs.
Antti Riikonen +3 more
wiley +1 more source
An Overview of Arrhythmias in Pregnancy
Methodist DeBakey Cardiovascular JournalCardiovascular disease significantly jeopardizes pregnancies in the United States, impacting 1% to 4% of pregnancies annually. Among complications, cardiac arrhythmias are prevalent, posing concerns for maternal and fetal health.
Kamala P. Tamirisa +4 more
doaj +1 more source
Cardiotoxicity of BRAF/MEK inhibitors
British Journal of Pharmacology, EarlyView.Abstract Rapidly accelerated fibrosarcoma type B/B‐Raf proto‐oncogene, serine/threonine kinase (BRAF) and mitogen‐activated protein kinase (MEK) inhibitors have transformed outcomes in cancer therapy, particularly in melanoma. However, cardiovascular toxicities are increasingly recognized in real‐world clinical practice.
Katharina Seuthe +4 more
wiley +1 more source
1C-INDUCED ATRIAL FLUTTER IN A PATIENT WITH WPW SYNDROME: CASE REPORT AND REVIEW
Рациональная фармакотерапия в кардиологии, 2015 The clinical case of a rare proarrhythmic effect of antiarrhythmic drugs with a poor prognosis (medication-induced atrial flutter in a patient with "malignant" Kent’s bundle) is presented.
R. R. Mamatkazina +4 more
doaj +3 more sources
Antiarrhythmic drug therapy prior to AF ablation.
, 2018 Antiarrhythmic drug therapy prior to AF ablation.
Rita Riedlbauer (6061223) +10 more
core +1 more source
Feasibility of Radiofrequency Catheter Ablation in the Treatment of Atrial Fibrillation
Український журнал серцево-судинної хірургії, 2020 Atrial fibrillation (AF) is a worldwide epidemic that has hit about 33 million people. In clinical studies, the efficacy of antiarrhythmic therapy and catheter ablation in the treatment of AF was compared, and controversial results were obtained ...
M. Meshkova, A. Doronin
doaj +1 more source
British Journal of Pharmacology, EarlyView.Abstract Background and Purpose Aberrant activation of type 2 ryanodine receptors (RyR2) causes lethal arrhythmias, such as catecholaminergic polymorphic ventricular tachycardia (CPVT). Developing drugs that suppress RyR2 hyperactivation may be key to novel arrhythmia treatments.
Nagomi Kurebayashi +29 more
wiley +1 more source